A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity
- PMID: 30183084
- DOI: 10.1002/ijc.31850
A new perspective: Exploring future therapeutic strategies for cancer by understanding the dual role of B lymphocytes in tumor immunity
Abstract
Our previous understanding of the role of B lymphocytes in tumor immunity is its antitumor effects. However, further evidence indicates B lymphocytes can also promote tumorigenesis by modulating immune responses. Therefore, the increasingly complex role of B lymphocytes in tumor immunity may become an important factor in tumor immunotherapy. In this review, we describe the development of B cells in tumor microenvironments. We then focus on the most controversial issues of the biological functions of B lymphocytes. Finally, we nominate B cells as therapeutic targets, which should open broad perspectives for the development of their clinical applications.
Keywords: B lymphocytes; immunotherapy; prognosis; regulatory B cells; tumor immunity.
© 2018 UICC.
Similar articles
-
The double-edge role of B cells in mediating antitumor T-cell immunity: Pharmacological strategies for cancer immunotherapy.Int Immunopharmacol. 2016 Jul;36:73-85. doi: 10.1016/j.intimp.2016.04.018. Epub 2016 Apr 22. Int Immunopharmacol. 2016. PMID: 27111515 Review.
-
The B-side of Cancer Immunity: The Underrated Tune.Cells. 2019 May 13;8(5):449. doi: 10.3390/cells8050449. Cells. 2019. PMID: 31086070 Free PMC article. Review.
-
The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A Review.Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):38-45. doi: 10.1016/j.ijrobp.2020.03.022. Epub 2020 Apr 3. Int J Radiat Oncol Biol Phys. 2020. PMID: 32251756 Review.
-
Duality of B Cell-CXCL13 Axis in Tumor Immunology.Front Immunol. 2020 Oct 21;11:521110. doi: 10.3389/fimmu.2020.521110. eCollection 2020. Front Immunol. 2020. PMID: 33193299 Free PMC article. Review.
-
[Intratumoral B cells and tertiary lymphoid structures are biomarkers of survival and immunotherapy responses].Bull Cancer. 2020 Apr;107(4):403-404. doi: 10.1016/j.bulcan.2020.02.008. Epub 2020 Apr 10. Bull Cancer. 2020. PMID: 32284150 French. No abstract available.
Cited by
-
Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma.Cancer Cell Int. 2023 Sep 27;23(1):218. doi: 10.1186/s12935-023-03065-8. Cancer Cell Int. 2023. PMID: 37759294 Free PMC article.
-
Peripheral immune characteristics of hepatitis B virus-related hepatocellular carcinoma.Front Immunol. 2023 Apr 3;14:1079495. doi: 10.3389/fimmu.2023.1079495. eCollection 2023. Front Immunol. 2023. PMID: 37077908 Free PMC article.
-
Chemical Characterization and Immunomodulatory Activity of Fucoidan from Sargassum hemiphyllum.Mar Drugs. 2022 Dec 26;21(1):18. doi: 10.3390/md21010018. Mar Drugs. 2022. PMID: 36662191 Free PMC article.
-
Identification of Immune-Related Subtypes and Characterization of Tumor Microenvironment Infiltration in Bladder Cancer.Front Cell Dev Biol. 2021 Aug 31;9:723817. doi: 10.3389/fcell.2021.723817. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34532318 Free PMC article.
-
Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma.Front Oncol. 2021 Jun 21;11:647854. doi: 10.3389/fonc.2021.647854. eCollection 2021. Front Oncol. 2021. PMID: 34235074 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
